ARS PHARMACEUTICALS INC (SPRY) Stock Earnings & Estimates
USA - NASDAQ:SPRY - US82835W1080 - Common Stock
9.03 USD
-0.36 (-3.83%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.32M | 30K -97.73% | 89.149M 297,063.33% | 82.314M -7.67% | 241.29M 193.13% | 405.97M 68.25% | 519.68M 28.01% | 747.08M 43.76% | 1.01B 35.19% | 954.73M -5.47% | 1.09B 14.17% | |
| EBITDA YoY % growth | -35.2M 60.36% | -67.447M -91.61% | -3.004M 95.55% | -150.236M -4,901.19% | -14.637M 90.26% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -35.52M 60.35% | -67.52M -90.09% | -3.083M 95.43% | -176.091M -5,611.67% | -79.826M 54.67% | 49.693M 162.25% | 118.67M 138.81% | 290.49M 144.79% | 513.5M 76.77% | 331.27M -35.49% | 450.91M 36.12% | |
| Operating Margin | -2,690.91% | -225,066.67% | -3.46% | -213.93% | -33.08% | 12.24% | 22.84% | 38.88% | 50.84% | 34.70% | 41.37% | |
| EPS YoY % growth | -0.98 61.72% | -0.57 41.84% | 0.05 108.77% | -1.68 -3,461.92% | -0.80 52.67% | 0.42 153.33% | 1.25 195.67% | 0.93 -26.02% | 1.65 78.02% | 2.46 48.77% | 3.33 35.27% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.48 -140.72% | -0.38 -177.85% | -0.37 -5.64% | -0.25 45.12% | -0.09 81.46% | -0.17 55.21% | -0.09 75.17% | 0.12 148.48% | 0.40 545.71% | 0.12 171.64% |
| Revenue Q2Q % growth | 29.531M 1,328.00% | 30.335M -64.96% | 34.433M 331.87% | 55.65M 254.08% | 74.352M 151.78% | 51.024M 68.20% | 70.278M 104.10% | 106.8M 91.91% | 157.64M 112.02% | 101.07M 98.08% |
| EBITDA Q2Q % growth | -38.801M -78.82% | -38.597M -181.64% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -49.751M -128.76% | -40.511M -185.83% | -36.036M 3.07% | -28.533M 40.07% | -3.327M 93.31% | -34.207M 15.56% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.46 -253.85% | -0.48 | 0.02 | 4.05% |
| Q1 2025 Q2Q % growth | -0.35 -218.18% | -0.35 | 0.00 | 1.02% |
| Q4 2024 Q2Q % growth | 0.49 800.00% | -0.14 | 0.63 | 443.14% |
| Q3 2024 Q2Q % growth | -0.20 -25.00% | -0.15 | -0.05 | -32.93% |
| Q2 2024 Q2Q % growth | -0.13 27.78% | -0.12 | -0.01 | -9.24% |
| Q1 2024 Q2Q % growth | -0.11 31.25% | -0.11 | 0.00 | 1.96% |
| Q4 2023 Q2Q % growth | -0.07 -109.09% | -0.14 | 0.07 | 50.98% |
| Q3 2023 Q2Q % growth | -0.16 68.00% | -0.19 | 0.03 | 14.13% |
| Q2 2023 Q2Q % growth | -0.18 67.27% | -0.18 | 0.00 | -1.61% |
| Q1 2023 Q2Q % growth | -0.16 77.14% | -0.17 | 0.01 | 6.45% |
| Q4 2022 Q2Q % growth | 0.77 214.93% | -0.13 | 0.90 | 680.69% |
| Q3 2022 Q2Q % growth | -0.50 23.08% | -0.36 | -0.14 | -38.08% |
| Q2 2022 Q2Q % growth | -0.55 21.43% | -0.49 | -0.06 | -11.56% |
| Q1 2022 Q2Q % growth | -0.70 -29.63% | -0.55 | -0.15 | -28.04% |
| Q4 2021 Q2Q % growth | -0.67 51.09% | -0.72 | 0.05 | 6.43% |
| Q3 2021 Q2Q % growth | -0.65 | -0.69 | 0.04 | 5.45% |
| Q2 2021 Q2Q % growth | -0.70 | -0.54 | -0.16 | -28.68% |
| Q1 2021 Q2Q % growth | -0.54 | -0.36 | -0.18 | -49.13% |
| Q4 2020 Q2Q % growth | -1.37 | -0.50 | -0.87 | -174.11% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 15.717M 3,043.40% | 14.052M | 1.665M | 11.85% |
| Q1 2025 Q2Q % growth | 7.973M | 7.631M | 342K | 4.48% |
| Q4 2024 Q2Q % growth | 86.581M | 16.134M | 70.447M | 436.64% |
| Q3 2024 Q2Q % growth | 2.068M | 586.5K | 1.482M | 252.60% |
| Q2 2024 Q2Q % growth | 500K 4,900.00% | 1.02M | -520K | -50.98% |
| Q1 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | 1.32M | 96.39K | 1.224M | 1,269.44% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.78% | -15.59% | -0.28% | -11.98% |
| Revenue | 1.24% | -2.08% | -1.34% | 1.47% |